Close
Digital Health & Ai Innovation summit 2026
APE 2026

Press Releases

LivaNova VNS Therapy System, Symmetry, Granted CE Mark for Difficult-to-Treat Depression

LivaNova PLC, a market-leading medical technology and innovation company, announced its Vagus Nerve Stimulation Therapy® (VNS Therapy) System, Symmetry™, earned CE Mark approval for Difficult-to-Treat...

AI-Pathway Companion Prostate Cancer from Siemens Healthineers approved for use in Europe as medical device

AI-Pathway Companion Prostate Cancer, a digital companion from Siemens Healthineers to support clinical decision-making, has recently received the CE mark for use in the clinical...

Nexelis to Acquire Specialty Immunogenicity and Immune-Oncology Testing Laboratory ImmunXperts

Nexelis, a portfolio company of Ampersand Capital Partners, and a leading provider of assay development and advanced laboratory testing is pleased to announce the signing...

American Oncology Network Continues Strategic Relationship with AmerisourceBergen

global healthcare solutions leader AmerisourceBergen announced that it is continuing its strategic relationship with the American Oncology Network, LLC (AON), a high-growth medical oncology provider...

V-Wave Receives CE Mark for the Ventura Interatrial Shunt System

CE Mark for the Ventura™ Interatrial Shunt System is a significant milestone for V-Wave, as it recognizes that this therapeutic product conforms to the standards...

Syndigo Introduces Comprehensive Global UDI Solution for Medical Device Manufacturers via CXH

Syndigo, a leading provider of verified product content syndication services, announced the addition of Unique Device Identifier (UDI) compliant product information for medical device manufacturers,...

SAM Medical Launches New SAM IO Intraosseous Access System

SAM Medical, an industry leader committed to developing and manufacturing the most innovative trauma care medical devices, announced the launch of the SAM IO Intraosseous...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read

Translate »